Example: Heart Attack

Search clinical trials for: Antibiotics, Antineoplastic

Total 4371 results

NCT04582305

Not yet recruiting

Bleomycin Jet Injections in Keloids

Conditions: Keloid
NCT03477448

Unknown status

The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts

Conditions: Warts
NCT04281290

Recruiting

Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)

Conditions: Pancreas Cancer
NCT04233697

Withdrawn

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Conditions: Lymphoma, T-Cell
NCT04139070

Recruiting

Electrochemotherapy for Non-curable Gastric Cancer

Conditions: Gastric Cancer
NCT04046679

Not yet recruiting

Bleomycin Infusion (MMP®) to Repigment Achromic Scars

Conditions: SCAR
NCT03820908

Completed

Bisantrene for Relapsed /Refractory AML

Conditions: Acute Myelogenous Leukemia; Allogeneic Stem Cell Transplantation
NCT03770000

Recruiting

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Conditions: T Cell Lymphoma
NCT03742921

Recruiting

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Conditions: Lymphoma, T-Cell, Peripheral
NCT03040180

Recruiting

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Conditions: Locally Advanced Rectal Cancer; Electrochemotherapy; Neoadjuvant Therapy; Down Staging
NCT03388749

Recruiting

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

Conditions: Leukemia, Myeloid, Acute
NCT03355768

Withdrawn

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Conditions: Lymphoma, T-Cell, Peripheral
NCT03315039

Active, not recruiting

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

Conditions: Leukemia, Myeloid, Acute
NCT03225781

Terminated

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT03141203

Active, not recruiting

Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients

Conditions: Peripheral T Cell Lymphoma
NCT02883023

Unknown status

Electrosclerotherapy for Capillary Malformations

Conditions: Capillary Malformations; Vascular Malformations
NCT02757248

Withdrawn

Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL

Conditions: PTCL; CTCL
NCT02616965

Recruiting

A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Conditions: Cutaneous T-cell Lymphoma (CTCL)
NCT02616874

Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Conditions: HIV
NCT02549742

Unknown status

Electrochemotherapy on Head and Neck Cancer

Conditions: Head Neck Cancer
NCT01872923

Completed

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Conditions: Cutaneous or Sub-cutaneous Malignancies
NCT02352259

Completed

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

Conditions: Liver Metastases
NCT02296398

Completed

Long-term Use of Romidepsin in Patients With CTCL

Conditions: Cutaneous T-cell Lymphoma
NCT02291133

Completed

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

Conditions: Liver Cancer
NCT02209701

Terminated

Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

Conditions: Head and Neck Neoplasms